Notes to Condensed Consolidated Financial Statements
(unaudited)
1. Nature of Operations and Basis of Presentation
Atlas Financial Holdings, Inc. (“Atlas” or “We” or the “Company”) commenced operations on December 31, 2010. The primary business of Atlas focuses on a managing general agency strategy, primarily through our wholly owned subsidiary, Anchor Group Management, Inc. (“AGMI”). AGMI focuses on a niche market orientation for the “light” commercial automobile sector. This sector includes taxi cabs, non-emergency para-transit, limousine, livery, including certain transportation network companies (“TNC”) drivers/operators, and business autos. Automobile insurance products provide insurance coverage in three major areas: liability, accident benefits and physical damage.
Atlas’ business is carried out through its non-insurance company subsidiaries: AGMI, UBI Holdings Inc. (“UBI Holdings”) and UBI Holdings’ wholly-owned subsidiaries, optOn Digital IP Inc. (“OOIP”) and optOn Insurance Agency Inc. (“optOn” and together with OOIP and UBI Holdings, “UBI”).
Prior to a strategic transition, our core business was the underwriting of commercial automobile insurance policies, focusing on the “light” commercial automobile sector, through American Country Insurance Company (“American Country”), American Service Insurance Company, Inc. (“American Service”) and Gateway Insurance Company (“Gateway” and together with American Country and American Service, the “ASI Pool Companies”) and Global Liberty Insurance Company of New York (“Global Liberty” and together with the ASI Pool Companies, our “Insurance Subsidiaries”), along with our wholly owned managing general agency, AGMI. The ASI Pool Companies were placed into rehabilitation under the statutory control of the Illinois Department of Insurance during the second half of 2019 and were subsequently placed into liquidation and have been deconsolidated from our consolidated financial statements as of October 1, 2019 as a result of these actions. Other regulatory actions were taken in certain states, including restriction, suspension, or revocation of certain state licenses and certificates of authority held by the ASI Pool Companies preceding and following the initiation of rehabilitation.
During the fourth quarter of 2019, the Company began actively pursuing the potential sale of Global Liberty Insurance Company of New York (“Global Liberty”), and as a result, Global Liberty has been classified as a discontinued operation since October 1, 2019.
Atlas’ ordinary common shares are listed on the OTC Markets system under the symbol “AFHIF”.
Basis of Presentation
These statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The consolidated financial statements include the accounts of Atlas and the entities it controls. Equity investments in entities that we do not consolidate, including corporate entities in which we have significant influence and partnership and partnership-like entities in which we have more than minor influence over operating and financial policies, are accounted for under the equity method unless we have elected the fair value option. All significant intercompany accounts and transactions have been eliminated.
The results for the three and six months ended June 30, 2021 are not necessarily indicative of the results expected for the full calendar year.
The accompanying unaudited condensed consolidated financial statements, in accordance with Securities and Exchange Commission (“SEC”) rules for interim periods, do not include all of the information and notes required by GAAP for complete financial statements and should be read in conjunction with Atlas’ Annual Report on Form 10-K for the year ended December 31, 2020, which provides a more complete understanding of the Company’s accounting policies, financial position, operating results, business properties, and other matters. Atlas has consistently applied the same accounting policies throughout all periods presented.
Estimates and Assumptions
The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and changes in estimates are recorded in the accounting period in which they are determined. Significant estimates in the accompanying financial statements include revenue recognition, evaluation of assets for impairment, deferred tax asset valuation, and allowances on premiums receivable.
Revenue Recognition
Revenues from contracts with customers include both commission and fee income. The recognition and measurement of revenue is based on the assessments of individual contract terms. As a managing general agency (an “MGA”), AGMI has contracts with various insurance carriers which determines AGMI’s commission income revenue. Each contract specifies what our performance obligations are as an MGA and what determines our commission income revenue, generally a percentage of gross written premiums, net of cancellations and refunds. Under these contracts there are a number of performance obligations; however, it is the bundle of these services and not a single obligation that results in the performance of the MGA under the contracts. The Company considers these performance obligations as a non-bifurcated bundle of services where the performance obligations are satisfied simultaneous to the point in time where the Company issues a policy, or cancels a policy to an insured. The commission rate stated in the individual contract is the standalone selling price of these non-bifurcated services, which is allocated to the service bundle and not to any individual obligation under the various contracts.
Seasonality
The property and casualty (“P&C”) insurance business is seasonal in nature. Our ability to generate commission income is also impacted by the timing of policy effective periods in the states in which we operate and products provided by our business partners. For example, January 1st and March 1st are common taxi cab renewal dates in Illinois and New York, respectively.
Operating Segments
The Company operates in one business segment, the Managing General Agency segment.
2. New Accounting Standards
There have been no recent pronouncements or changes in pronouncements during the six months ended June 30, 2021, as compared to those described in our Annual Report on Form 10-K for the twelve months ended December 31, 2020, that are of significance or potential significance to Atlas. Pertinent Accounting Standard Updates (“ASUs”) are issued from time to time by the Financial Accounting Standards Board (“FASB”) and are adopted by the Company as they become effective. All recently issued accounting pronouncements with effective dates prior to July 1, 2021 have been adopted by the Company.
3. Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible Assets by Major Asset Class
|
($ in ‘000s)
|
Economic Useful Life
|
Gross Carrying Amount
|
Accumulated Amortization
|
Net
|
As of June 30, 2021
|
|
|
|
|
Trade name and trademark
|
15 years
|
$
|
1,800
|
|
$
|
764
|
|
$
|
1,036
|
|
Customer relationship
|
10 years
|
2,700
|
|
1,696
|
|
1,004
|
|
|
|
$
|
4,500
|
|
$
|
2,460
|
|
$
|
2,040
|
|
|
|
|
|
|
As of December 31, 2020
|
|
|
|
|
Trade name and trademark
|
15 years
|
$
|
1,800
|
|
$
|
703
|
|
$
|
1,097
|
|
Customer relationship
|
10 years
|
2,700
|
|
1,562
|
|
1,138
|
|
|
|
$
|
4,500
|
|
$
|
2,265
|
|
$
|
2,235
|
|
|
|
|
|
|
4. Income (Loss) From Continuing Operations per Share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Computations of Basic and Diluted Income (Loss) per Common Share from Continuing Operations
|
($ in ‘000s, except share and per share amounts)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Basic
|
|
|
|
|
Income (loss) from continuing operations before income taxes
|
$
|
660
|
|
$
|
(4,858)
|
|
$
|
(2,042)
|
|
$
|
(7,988)
|
|
Income tax benefit
|
—
|
|
(227)
|
|
—
|
|
(123)
|
|
Net income (loss) attributable to common shareholders from continuing operations
|
$
|
660
|
|
$
|
(4,631)
|
|
$
|
(2,042)
|
|
$
|
(7,865)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding
|
12,047,334
|
|
11,874,653
|
|
12,035,560
|
|
11,855,882
|
|
Income (loss) per common share basic from continuing operations
|
$
|
0.06
|
|
$
|
(0.39)
|
|
$
|
(0.17)
|
|
$
|
(0.66)
|
|
|
|
|
|
|
Diluted
|
|
|
|
|
Basic weighted average common shares outstanding
|
12,047,334
|
|
11,874,653
|
|
12,035,560
|
|
11,855,882
|
|
Dilutive potential ordinary shares:
|
|
|
|
|
Dilutive stock options outstanding
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
|
|
|
Diluted weighted average common shares outstanding
|
12,047,334
|
|
11,874,653
|
|
12,035,560
|
|
11,855,882
|
|
Income (loss) per common share diluted from continuing operations
|
$
|
0.06
|
|
$
|
(0.39)
|
|
$
|
(0.17)
|
|
$
|
(0.66)
|
|
Common shares are defined as ordinary voting common shares, restricted voting common shares and participative restricted stock units (“RSUs”). Earnings per common share diluted is computed by dividing net income (loss) by the weighted average number of common shares outstanding for each period plus the incremental number of shares added as a result of converting dilutive potential ordinary voting common shares, calculated using the treasury stock method. Atlas’ potential dilutive ordinary voting common shares consists of outstanding stock options to purchase ordinary voting common shares and warrants to purchase 2,387,368 ordinary voting common shares of Atlas for $0.69 per share.
Atlas’ dilutive potential ordinary voting common shares consist of outstanding stock options to purchase ordinary voting common shares. The effects of these convertible instruments are excluded from the computation of earnings per common share diluted from continuing operations in periods in which the effect would be anti-dilutive. For the three and six months ended June 30, 2021 and 2020, all exercisable stock options were deemed to be anti-dilutive.
5. Contracts with Customers
The revenue included as commission income was $1.8 million and $951,000 for the three months ended June 30, 2021 and 2020, respectively, and $3.5 million and $3.0 million for the six months ended June 30, 2021 and 2020, respectively.
The balance of receivables related to contracts with customers, which is recorded as part of premiums receivable on the Condensed Consolidated Statements of Financial Position as of June 30, 2021 and December 31, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
Components of Commission Receivables
|
($ in ‘000s)
|
June 30, 2021
|
December 31, 2020
|
Commission receivable, beginning of period
|
$
|
2,577
|
|
$
|
1,428
|
|
Commission revenue
|
3,484
|
|
5,195
|
|
Net change in cash received
|
(3,543)
|
|
(4,046)
|
|
Commission receivable, end of period
|
$
|
2,518
|
|
$
|
2,577
|
|
|
|
|
|
6. Income Taxes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate - Continuing Operations
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Provision for taxes at U.S. statutory marginal income tax rate
|
$
|
139
|
|
21.0
|
%
|
$
|
(1,020)
|
|
21.4
|
%
|
$
|
(429)
|
|
21.0
|
%
|
$
|
(1,677)
|
|
21.2
|
|
Provision for deferred tax assets deemed unrealizable (valuation allowance)
|
826
|
|
125.1
|
|
792
|
|
(16.6)
|
|
1,386
|
|
(67.9)
|
|
1,583
|
|
(19.9)
|
|
Nondeductible expenses
|
1
|
|
0.1
|
|
1
|
|
—
|
|
2
|
|
(0.1)
|
|
1
|
|
—
|
|
Stock compensation
|
—
|
|
—
|
|
—
|
|
—
|
|
7
|
|
(0.3)
|
|
12
|
|
(0.2)
|
|
Gain from debt extinguishment
|
(966)
|
|
(146.2)
|
|
—
|
|
—
|
|
(966)
|
|
47.3
|
|
—
|
|
—
|
|
Tax rate differential
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(42)
|
|
0.5
|
|
Provision for income taxes for continuing operations
|
$
|
—
|
|
—
|
%
|
$
|
(227)
|
|
4.8
|
%
|
$
|
—
|
|
—
|
%
|
$
|
(123)
|
|
1.6
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of U.S. Statutory Marginal Income Tax Rate to the Effective Tax Rate - Discontinued Operations
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Amount
|
%
|
Provision for taxes at U.S. statutory marginal income tax rate
|
$
|
—
|
|
—
|
%
|
$
|
(20)
|
|
21.0
|
%
|
$
|
32
|
|
21.0
|
%
|
$
|
(142)
|
|
21.0
|
%
|
Provision for deferred tax assets deemed unrealizable (valuation allowance)
|
—
|
|
—
|
|
22
|
|
(21.2)
|
|
(32)
|
|
(21.0)
|
|
(180)
|
|
26.3
|
|
Nondeductible expenses
|
—
|
|
—
|
|
(2)
|
|
0.2
|
|
—
|
|
—
|
|
—
|
|
—
|
|
|
|
|
|
|
|
|
|
|
Tax rate differential
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
(200)
|
|
29.2
|
|
Provision for income taxes for discontinued operations
|
$
|
—
|
|
—
|
%
|
$
|
—
|
|
—
|
%
|
$
|
—
|
|
—
|
%
|
$
|
(522)
|
|
76.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of Income Tax Expense - Continuing Operations
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Current tax benefit
|
$
|
—
|
|
$
|
(227)
|
|
$
|
—
|
|
$
|
(123)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Components of Income Tax Benefit - Discontinued Operations
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Current tax benefit
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
(522)
|
|
|
|
|
|
|
During 2013 and 2019, due to shareholder activity, “triggering events” as determined under IRC Section 382 may have occurred. As a result, under IRC Section 382, the use of the Company’s net operating loss (“NOL”) and other carryforwards generated prior to the “triggering events” may be subject to a yearly limitation as a result of this “ownership change” for tax purposes, which is defined as a cumulative change of more than 50% during any three-year period by shareholders owning 5% or greater portions of the Company’s shares. Due to the mechanics of the Section 382 calculation when there are multiple triggering events, the Company’s losses will generally be limited based on the thresholds of the 2019 triggering event. The Company has established a valuation allowance against the NOLs that will expire unused as a result of the yearly limitation.
|
|
|
|
|
|
|
|
|
Components of Deferred Income Tax Assets and Liabilities
|
($ in ‘000s)
|
June 30, 2021
|
December 31, 2020
|
Gross deferred tax assets:
|
|
|
Losses carried forward
|
$
|
17,200
|
|
$
|
16,408
|
|
Claims liabilities and unearned premium reserves
|
487
|
|
496
|
|
Investment in affiliates
|
23,870
|
|
23,870
|
|
Bad debts
|
168
|
|
168
|
|
Stock compensation
|
305
|
|
279
|
|
Other
|
419
|
|
203
|
|
Valuation allowance
|
(34,813)
|
|
(33,420)
|
|
Total gross deferred tax assets
|
7,636
|
|
8,004
|
|
|
|
|
Gross deferred tax liabilities:
|
|
|
Deferred policy acquisition costs
|
69
|
|
134
|
|
Investments
|
81
|
|
122
|
|
Fixed assets
|
826
|
|
1,344
|
|
Intangible assets
|
429
|
|
469
|
|
Other
|
6,231
|
|
5,935
|
|
Total gross deferred tax liabilities
|
7,636
|
|
8,004
|
|
Net deferred tax assets
|
$
|
—
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Operating Loss Carryforward as of June 30, 2021 by Expiry
|
($ in ‘000s)
|
|
|
Year of Occurrence
|
Year of Expiration
|
Amount
|
2011
|
2031
|
$
|
1
|
|
2012
|
2032
|
70
|
|
2015
|
2035
|
1
|
|
2017
|
2037
|
13,649
|
|
2018
|
2038
|
8,903
|
|
2018
|
Indefinite
|
8,245
|
|
2019
|
2039
|
4,973
|
|
2019
|
Indefinite
|
6,306
|
|
2020
|
2040
|
31,300
|
|
2020
|
Indefinite
|
4,687
|
|
2021
|
2041
|
873
|
|
2021
|
Indefinite
|
2,896
|
|
Total
|
|
$
|
81,904
|
|
|
|
|
Deferred tax assets are recognized to the extent that it is probable that future taxable income will be available against which they can be utilized. When considering the extent of the valuation allowance on Atlas’ deferred tax assets, weight is given by management to both positive and negative evidence. GAAP states that a cumulative loss in recent years is a significant piece of negative evidence that is difficult to overcome in determining that a valuation allowance is not needed against deferred tax assets. Based on Atlas’ cumulative loss in recent years and certain deferred tax assets subject to a yearly limitation under Section 382 which will likely result in expiration before utilization, Atlas has recorded a valuation allowance of $34.8 million and $33.4 million for its gross future deferred tax assets as of June 30, 2021 and December 31, 2020, respectively.
Atlas accounts for uncertain tax positions in accordance with the income taxes accounting guidance. Atlas has analyzed filing positions in the federal and state jurisdictions where it is required to file tax returns, as well as the open tax years in these jurisdictions. Atlas believes that its federal and state income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material change to its financial position. Therefore, no reserves for uncertain federal and state income tax positions have been recorded. Atlas would recognize interest and penalties related to unrecognized tax benefits as a component of the provision for federal income taxes. Atlas did not incur any federal income tax related interest income, interest expense or penalties for the three and six months ended June 30, 2021 and 2020. Tax year 2017 and years thereafter are subject to examination by the Internal Revenue Service (“IRS”).
7. Commitments and Contingencies
In the ordinary course of its business, Atlas is involved in legal proceedings, including lawsuits, regulatory examinations and inquiries.
Atlas is exposed to credit risk on balances receivable from insureds and agents. Credit exposure to any one individual insured is not material. The policies placed with risk taking partners are distributed by agents who may manage cash collection on its behalf pursuant to the terms of their agency agreement. Atlas has procedures to monitor and minimize its exposure to delinquent agent balances, including, but not limited to, reviewing agent account statements, processing policy cancellations for non-payment and other collection efforts deemed appropriate.
8. Property and Equipment
|
|
|
|
|
|
|
|
|
Property and Equipment Held
|
($ in ‘000s)
|
June 30, 2021
|
December 31, 2020
|
Buildings1
|
$
|
—
|
|
$
|
7,425
|
|
Land1
|
—
|
|
1,840
|
|
Building improvements1
|
—
|
|
9,031
|
|
Leasehold improvements
|
182
|
|
193
|
|
Internal use software
|
12,795
|
|
12,795
|
|
Computer equipment
|
1,838
|
|
1,838
|
|
Furniture and other office equipment
|
1,097
|
|
1,121
|
|
Total
|
$
|
15,912
|
|
$
|
34,243
|
|
Accumulated depreciation and amortization
|
(12,652)
|
|
(15,428)
|
|
Total property and equipment, net
|
$
|
3,260
|
|
$
|
18,815
|
|
|
|
|
1 Held for sale
Depreciation expense and amortization from continuing operations was $394,000 and $854,000 for the three months ended June 30, 2021 and 2020, respectively, and $1.1 million and $1.7 million for the six months ended June 30, 2021 and 2020, respectively. For the year ended December 31, 2020, depreciation expense and amortization from continuing operations was $3.2 million.
For the six months ended June 30, 2021 and 2020, the Company capitalized $0 and $186,000, respectively, of costs incurred, consisting primarily of external consultants and internal labor costs incurred during the application development stage for internal-use software. Substantially all of the costs incurred during the period were part of the application development stage. Amortization expense recorded for projects in the post-implementation/operation stage was $302,000 and $404,000 for the three months ended June 30, 2021 and 2020, respectively, and $604,000 and $806,000 for the six months ended June 30, 2021 and 2020, respectively.
During 2016, Atlas purchased a building and land to serve as its new corporate headquarters to replace its former leased office space. Atlas’ Chicago area staff moved into this space in late October 2017 and occupies approximately 70,000 square feet in the building. An unrelated tenant occupies the remaining office space in the building. Rental income related to this lease agreement was $119,000 and $76,000 for the three months ended June 30, 2021 and 2020, respectively, and $238,000 and $230,000 for the six months ended June 30, 2021 and 2020, respectively. Depreciation expense related to the building and its improvements was $0 and $284,000 for the three months ended June 30, 2021 and 2020, respectively, and $284,000 and $549,000 for the six months ended June 30, 2021 and 2020, respectively. The decrease in depreciation expense for its corporate headquarters is a result of the held for sale status of the corporate headquarters.
On April 1, 2021, the Company transitioned the assets related to its corporate headquarters from long-lived asset as held and used to long-lived assets held for sale. The Company has engaged an independent third party which is actively marketing the sale of the corporate headquarters including the land, building, building improvements and contents including furniture and fixtures and a sale is expected to close within one year from the classification transition date. The assets transferred totaled $13.0 million which were previously classified as property and equipment, net on the condensed consolidated statements of financial position and now included as part of assets held for sale. The Company performed an evaluation of the net book value of the assets and recorded an impairment of $1.5 million which is recorded as part of net realized losses on the condensed consolidated statements of operations for the three and six months ended June 30, 2021.
Realized gains on disposals of fixed assets totaled $0 and $12,000 for the three and six months ended June 30, 2021, respectively. There were no losses on disposals of fixed assets for each of the three and six months ended June 30, 2020.
9. Share-Based Compensation
On January 6, 2011, Atlas adopted a stock option plan (“Stock Option Plan”) in order to advance the interests of Atlas by providing incentives to eligible persons defined in the plan. In the second quarter of 2013, a new equity incentive plan (“Equity Incentive Plan”) was approved by the Company’s common shareholders at the Annual General Meeting, and Atlas ceased to grant new stock options under the preceding Stock Option Plan. The Equity Incentive Plan is a securities based compensation plan, pursuant to which Atlas may issue restricted stock grants for ordinary voting common shares, restricted stock, stock grants for ordinary voting common shares, stock options and other forms of equity incentives to eligible persons as part of their compensation. The Equity Incentive Plan is considered an amendment and restatement of the Stock Option Plan, although outstanding stock options issued pursuant to the Stock Option Plan will continue to be governed by the terms of the Stock Option Plan.
Stock Options
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock Option Activity
|
|
|
|
|
(prices in Canadian dollars designated with “C$” and U.S. dollars designated with “US$”
|
Six months ended June 30,
|
2021
|
2020
|
|
Number of Options
|
Weighted Average Exercise Price
|
Number of Options
|
Weighted Average Exercise Price
|
C$ Denominated:
|
|
|
|
|
Outstanding, beginning of period
|
—
|
|
C$—
|
27,195
|
|
C$6.00
|
Granted
|
—
|
|
—
|
|
—
|
|
—
|
|
Exercised
|
—
|
|
—
|
|
—
|
|
—
|
|
Canceled
|
—
|
|
—
|
|
—
|
|
—
|
|
Outstanding, end of period
|
—
|
|
C$—
|
27,195
|
|
C$6.00
|
|
|
|
|
|
US$ Denominated:
|
|
|
|
|
Outstanding, beginning of period
|
181,500
|
|
US$13.51
|
375,000
|
|
US$17.01
|
Granted
|
1,016,000
|
|
0.49
|
|
—
|
|
—
|
|
Exercised
|
—
|
|
—
|
|
—
|
|
—
|
|
Canceled
|
—
|
|
—
|
|
(193,500)
|
|
18.73
|
|
Outstanding, end of period
|
1,197,500
|
|
US$2.63
|
181,500
|
|
US$13.51
|
|
|
|
|
|
There are 401,500 stock options that are exercisable as of June 30, 2021. The stock option grants outstanding have a weighted average remaining life of 6.22 years and have a fair value of $0 as of June 30, 2021.
On March 12, 2015, the Board of Directors of Atlas granted equity awards of (i) 200,000 restricted stock grants for ordinary voting common shares of the Company and (ii) 200,000 options to acquire ordinary voting common shares to the executive officers of the Company as part of the Company’s annual compensation process. The awards were made under the Company’s Equity Incentive Plan. The awards vest in five equal annual installments of 20%, provided that an installment shall not vest unless an annual performance target based on specific book value growth rates linked to return on equity goals is met. In the event the performance target is not met in any year, the 20% installment for such year shall not vest, but such non-vested installment shall carry forward and can become vested in future years (up to the fifth year from the date of grant), subject to achievement in a future year of the applicable performance target for such year. For the three and six months ended June 30, 2021 and 2020, no shares of either of the restricted stock grants for ordinary voting common shares or the options to acquire ordinary voting common shares vested due to not meeting annual performance targets. During the first quarter of 2020, 140,000 of the option awards were canceled as a result of not meeting the annual performance targets. Also during the first quarter of 2020, an additional 53,500 options were canceled due to the departure of a former officer. The Monte-Carlo simulation model was used, for both the options and restricted stock grants for ordinary voting common shares, to estimate the fair value of compensation expense as a result of the performance based component of these grants. Utilizing the Monte-Carlo simulation model, the fair values were $1.5 million and $1.9 million for the options and restricted stock grants for ordinary voting common shares, respectively. This expense will be amortized over the anticipated vesting period.
On April 22, 2021, the Company granted an aggregate of 1,016,000 options (“Options”) with an exercise price of $0.49 per common share of the Company to directors, managers, and executives pursuant to the Company’s Equity Incentive Plan. This exercise price is the average of the high bid and low asked prices on the date of the grant quoted on the OTC Bulletin Board Service. The Options granted to management shall vest in three equal installments, with each installment vesting on the 1st, 2nd and 3rd anniversary of the date of the grant. The Options granted to independent directors vested immediately upon the date of the grant. The Options will expire on the 7th anniversary of the date of the grant. In the event of a change of control of the Company, or should a director’s or employee’s service with the Company be terminated other than for cause or voluntary resignation, any unvested Options will immediately vest. The estimated fair values of the Options are amortized to expense over the Options’ vesting period. The Company estimated the fair value of the Options at the date of the grant using the Black-Scholes option pricing model with the following weighted average assumptions:
|
|
|
|
|
|
|
2021
|
Expected risk-free interest rate
|
1.6
|
%
|
Volatility
|
180.8
|
%
|
Expected life (in years)
|
7.0
|
|
|
On December 31, 2018, the Company awarded restricted stock unit grants for ordinary voting common shares of the Company to its external directors pursuant to a director equity award agreement dated December 31, 2018. The awards, which were approved by the Company’s Board of Directors in March 2018, were valued at $40,000 per external director (“Aggregate Award”) and were made under the Company’s Equity Incentive Plan. The number of restricted stock units awarded was determined by dividing (A) the Aggregate Award by (B) the closing price of a Company ordinary voting common share at the close of market on April 4, 2018, which was $10.50 per share. For new directors, the Aggregate Award is proportionate to the director’s start date and priced as of that same day. During 2018, the Company awarded 17,524 RSU grants having an aggregate grant date fair value of $179,000. As of June 30, 2021, all of the RSU grants have vested.
Restricted Shares
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Grants for Ordinary Voting Common Shares and Restricted Share Unit Activity
|
|
Six months ended June 30,
|
|
2021
|
2020
|
|
Number of Shares
|
Weighted Average Fair Value at Grant Date
|
Number of Shares
|
Weighted Average Fair Value at Grant Date
|
Non-vested, beginning of period
|
$
|
3,301
|
|
$
|
10.22
|
|
$
|
171,682
|
|
$
|
17.46
|
|
Granted
|
—
|
|
—
|
|
—
|
|
—
|
|
Vested
|
(3,301)
|
|
0.12
|
|
(5,841)
|
|
10.22
|
|
Canceled
|
—
|
|
—
|
|
(160,000)
|
|
9.62
|
|
Non-vested, end of period
|
$
|
—
|
|
$
|
—
|
|
$
|
5,841
|
|
$
|
10.22
|
|
|
|
|
|
|
During the first quarter of 2020, 140,000 ordinary voting restricted common shares were canceled as a result of not meeting annual performance targets. Also during the first quarter of 2020, an additional 20,000 restricted common shares were canceled due to the departure of a former officer.
In accordance with ASC 718 (Stock-Based Compensation), Atlas has recognized share-based compensation expense on a straight-line basis over the requisite service period of the last separately vesting portion of the award. Share-based compensation expense is a component of other underwriting expenses on the condensed consolidated statements of operations. Atlas recognized $156,000 and $16,000 in share-based compensation expense, including income tax expense, for the three months ended June 30, 2021 and 2020, respectively, and $166,000 and $195,000 for the six months ended June 30, 2021 and 2020, respectively. As of June 30, 2021, there was no unrecognized total compensation expense related to restricted stock and restricted stock units for ordinary voting common shares.
10. Other Employee Benefit Plans
Defined Contribution Plan
Atlas has a defined contribution 401(k) plan covering all qualified employees of Atlas and its subsidiaries. Contributions to this plan are limited based on IRS guidelines. Atlas may match up to 100% of the employee contribution up to 2.5% of annual earnings, plus 50% of additional contributions up to 2.5% of annual earnings, for a total maximum expense of 3.75% of annual earnings per participant. Atlas’ matching contributions are discretionary. Employees are 100% vested in their own contributions and vest in Atlas contributions based on years of service equally over 5 years with 100% vested after 5 years. Company contributions were $0 and $48,000 for the three months ended June 30, 2021 and 2020, respectively, and $0 and $58,000 for the six months ended June 30, 2021 and 2020, respectively. The matching portion of this plan was suspended during the third quarter of 2020.
Employee Stock Purchase Plan
The Atlas Employee Stock Purchase Plan (“ESPP”) encourages employee interest in the operation, growth and development of Atlas and provides an additional investment opportunity to employees. Full time and permanent part time employees working more than 30 hours per week are allowed to invest up to 7.5% of adjusted salary in Atlas ordinary voting common shares. Atlas may match up to 100% of the employee contribution up to 2.5% of annual earnings, plus 50% of additional contributions up to 5% of annual earnings, for a total maximum expense of 5% of annual earnings per participant. Atlas’ matching contributions are discretionary. Atlas also pays all administrative costs related to this plan. Atlas’ costs incurred related to the matching portion of the ESPP were $0 and $13,000 for the three months ended June 30, 2021 and 2020, respectively, and $0 and $16,000 for the six months ended June 30, 2021 and 2020, respectively. The matching portion of this plan was suspended during the third quarter of 2020.
11. Share Capital and Mezzanine Equity
Share Capital
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Capital Activity
|
|
|
June 30, 2021
|
December 31, 2020
|
|
Shares Authorized1
|
Shares Issued
|
Shares Outstanding
|
Amount
($ in ‘000s)
|
Shares Issued
|
Shares Outstanding
|
Amount
($ in ‘000s)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ordinary voting common shares
|
266,666,667
|
|
12,302,839
|
|
12,047,334
|
|
$
|
37
|
|
12,248,798
|
|
11,993,293
|
|
$
|
37
|
|
Restricted voting common shares
|
33,333,334
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
—
|
|
Total common shares
|
300,000,001
|
|
12,302,839
|
|
12,047,334
|
|
$
|
37
|
|
12,248,798
|
|
11,993,293
|
|
$
|
37
|
|
|
|
|
|
|
|
|
|
1 Shares authorized increased from 266,666,667 to 800,000,001 effective July 12, 2021
There were 0 and 3,301 non-vested RSUs as of June 30, 2021 and December 31, 2020, respectively. These RSUs are participative and are included in the computations of earnings per common share and book value per common share for these periods.
During the six months ended June 30, 2021, the Company issued 54,041 ordinary voting common shares of which 50,740 ordinary voting common shares were issued under the near term incentive program while 3,301 ordinary voting common shares were issued as a result of the vesting of RSUs. During the year ended December 31, 2020, the Company issued 210,481 ordinary voting common shares of which 202,100 ordinary voting common shares were issued under the near term incentive program while 8,381 ordinary voting common shares were issued as a result of the vesting of RSUs. Also, during the year ended December 31, 2020, 140,000 ordinary voting restricted common shares were canceled due to not meeting performance targets, and 20,000 ordinary voting restricted common shares were canceled due to the departure of a former officer.
Warrants
The Schedule 13G/A filed by American Financial Group, Inc. a parent holding company, on February 2, 2021 states that as of December 31, 2020, it has sole power to vote and sole power to dispose of 2,387,368 ordinary voting common shares. These shares are represented by warrants to purchase 2,387,368 ordinary voting common shares until June 10, 2024, under a Warrant Agreement dated June 10, 2019 (the “Warrant Agreement”), at an initial exercise price of $0.69 per share, with both the number of ordinary voting common shares subject to the Warrant Agreement and the exercise price subject to adjustment as set forth in the Warrant Agreement.
Mezzanine Equity
There were no preferred shares outstanding as of June 30, 2021 and December 31, 2020.
12. Leases
We currently lease real estate space, automobiles, and certain equipment under non-cancelable operating lease agreements. Leases with an initial term of 12 months or less, which are immaterial to the Company, are not recorded in the condensed consolidated statement of financial position. The Company has elected the practical expedient to account for each separate lease component of a contract and its associated non-lease components as a single lease component, thus causing all fixed payments to be capitalized. The Company also elected the package of practical expedients permitted within the new standard, which among other things, allows the Company to carry forward historical lease classification. Variable lease payment amounts that cannot be determined at the commencement of the lease, such as increases to lease payments based on changes in index rates or usage, are not recorded in the condensed consolidated statements of financial position.
Certain agreements include an option to extend or renew the lease term at our option. The operating lease liability includes lease payments related to options to extend or renew the lease term if the Company is reasonably certain of exercising those options. Lease payments are discounted using the implicit discount rate in the lease. If the implicit discount rate for the lease cannot be readily determined, the Company uses an estimate of its incremental borrowing rate. The Company did not have any contracts accounted for as finance leases as of June 30, 2021 or 2020.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lease Expense
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Operating leases
|
$
|
169
|
|
$
|
190
|
|
$
|
338
|
|
$
|
380
|
|
Variable lease cost
|
91
|
|
91
|
|
183
|
|
180
|
|
Total
|
$
|
260
|
|
$
|
281
|
|
$
|
521
|
|
$
|
560
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Operating Lease Information
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Cash paid for amounts included in the measurement of lease liabilities reported in operating cash flows
|
$
|
260
|
|
$
|
281
|
|
$
|
521
|
|
$
|
560
|
|
Right-of-use assets obtained in exchange for new lease liabilities
|
—
|
|
—
|
|
—
|
|
—
|
|
Total
|
$
|
260
|
|
$
|
281
|
|
$
|
521
|
|
$
|
560
|
|
|
|
|
|
|
The following table presents the undiscounted contractual maturities of the Company’s operating lease liability:
|
|
|
|
|
|
|
Contractual Operating Lease Liabilities
|
($ in ‘000s)
|
|
As of June 30, 2021
|
Remainder of 2021
|
|
$
|
448
|
|
2022
|
|
179
|
|
2023
|
|
23
|
|
|
|
|
|
|
|
Total lease payments
|
|
$
|
650
|
|
Impact of discounting
|
|
13
|
|
Operating lease liability
|
|
$
|
663
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Supplemental Balance Sheet Disclosures
|
($ in ‘000s)
|
|
|
Lease Component
|
Balance Sheet Classification
|
As of June 30, 2021
|
Lease right-of-use asset
|
Right-of-use asset
|
$
|
566
|
|
|
|
|
Weighted-average remaining lease term
|
|
0.8 years
|
Weighted-average discount rate
|
|
3.6
|
%
|
13. Related Party Transactions
During the year-ended December 31, 2020, a portion of Global Liberty’s investment portfolio, which is included in “Assets held for sale” on the Condensed Consolidated Statements of Financial Position, included investment vehicles that were considered related-party transactions. As of December 31, 2020, these related-party transactions made up approximately 22.5%, of the Company’s investment portfolio. In these transactions, one or more of the Company’s former directors or entities affiliated with such directors invest in and/or manage these vehicles. These related-party transactions are consistent with the Company’s investment guidelines and have been reviewed and approved by the Investment Committee of the Company’s Board of Directors. With the retirement of these former directors from the Atlas Board of Directors during 2020, these investments are no longer considered related-party transactions.
14. Notes Payable
On April 26, 2017, Atlas issued $25 million of five-year 6.625% senior unsecured notes and received net proceeds of approximately $23.9 million after deducting underwriting discounts and commissions and other estimated offering expenses. Interest on the senior unsecured notes is payable quarterly on each January 26, April 26, July 26 and October 26. Atlas may, at its option, beginning with the interest payment date of April 26, 2020, and on any scheduled interest payment date thereafter, redeem the senior unsecured notes, in whole or in part, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest to, but excluding, the date of redemption. The senior unsecured notes will rank senior in right of payment to any of Atlas’ existing and future indebtedness that is by its terms expressly subordinated or junior in right of payment to the senior unsecured notes. The senior unsecured notes will rank equally in right of payment to all of Atlas’ existing and future senior indebtedness, but will be effectively subordinated to any secured indebtedness to the extent of the value of the collateral securing such secured indebtedness. In addition, the senior unsecured notes will be structurally subordinated to the indebtedness and other obligations of Atlas’ subsidiaries.
The senior unsecured notes were issued under an indenture and supplemental indenture that contain covenants that, among other things, limit: (i) the ability of Atlas to merge or consolidate, or lease, sell, assign or transfer all or substantially all of its assets; (ii) the ability of Atlas to sell or otherwise dispose of the equity securities of certain of its subsidiaries; (iii) the ability of certain of Atlas’ subsidiaries to issue equity securities; (iv) the ability of Atlas to permit certain of its subsidiaries to merge or consolidate, or lease, sell, assign or transfer all or substantially all of their respective assets; and (v) the ability of Atlas and its subsidiaries to incur debt secured by equity securities of certain of its subsidiaries.
On November 10, 2016, American Insurance Acquisition, Inc. (“AIAI”) entered into a ten-year 5.0% fixed rate mortgage agreement with the Insurance Subsidiaries totaling $10.7 million with principal and interest payments due monthly. The mortgage rate is secured by the Company’s headquarters and was previously eliminated in consolidation. The amounts payable as of June 30, 2021 are due to the estates of the ASI Pool Companies.
On May 1, 2020, AIAI entered into a Paycheck Protection Program Promissory Note (the "PPP Note") with respect to a loan of $4,600,500 (the "PPP Loan") from Fifth Third Bank, National Association (“Fifth Third”). The PPP Loan was obtained pursuant to the Paycheck Protection Program (the "PPP") of the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") administered by the U.S. Small Business Administration ("SBA"). The PPP Loan had a maturity date of May 1, 2022 and interest at a rate of 1.0% per annum. On June 14, 2021, AIAI received notification from the SBA that the PPP Loan principal and related interest has been forgiven.
On February 7, 2021, AIAI entered into a Paycheck Protection Program Promissory Note with respect to a loan of $2,000,000 (the “Second PPP Loan”) from Fifth Third. The Second PPP Loan was obtained pursuant to the SBA’s Paycheck Protection Program Second Draw Loans under the Small Business Act (“SB Act”) and is subject to the terms and conditions of the SB Act, the CARES Act and related legislation and regulations (the “PPP Rules”). The Company was eligible for this Second PPP Loan because our equity securities are not a National Markets System stock traded on a national securities exchange as defined by Section 6 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The Second PPP Loan matures on February 7, 2026 and bears interest at a rate of 1.0% per annum. The Company will not be obligated to make any payments of principal or interest if the Company submits a loan forgiveness application to Fifth Third within 10 months after the end of the Company’s covered loan forgiveness period (as defined and interpreted by the PPP Rules) and such loan forgiveness is allowed. If the Company does not submit a loan forgiveness application within 10 months after the end of the Company’s loan forgiveness covered period (or such forgiveness is not allowed), the Company must begin paying principal and interest after that period (or after notice that such forgiveness is not allowed).
Interest expense on notes payable was $514,000 and $571,000 for the three months ended June 30, 2021 and 2020, respectively, and $1.1 million and $1.1 million for the six months ended June 30, 2021 and 2020, respectively.
|
|
|
|
|
|
|
|
|
Notes Payable Outstanding
|
($ in ‘000s)
|
June 30, 2021
|
December 31, 2020
|
6.625% Senior Unsecured Notes due April 26, 2022
|
$
|
25,000
|
|
$
|
25,000
|
|
1.0% PPP Loan due May 1, 2022
|
—
|
|
4,601
|
|
1.0% Second PPP Loan due February 7, 2026
|
2,000
|
|
—
|
|
5.0% Mortgage due November 10, 2026
|
6,538
|
|
6,863
|
|
Total outstanding borrowings
|
33,538
|
|
36,464
|
|
Unamortized issuance costs
|
(184)
|
|
(296)
|
|
Total notes payable
|
$
|
33,354
|
|
$
|
36,168
|
|
|
|
|
15. Deconsolidation and Discontinued Operations
Deconsolidation
As part of the deconsolidation of the ASI Pool Companies which occurred on October 1, 2019, notes receivable from the ASI Pool Companies with an outstanding principal and accrued interest balances of $18.0 million due to AIAI are presented on the condensed consolidated statements of financial position. On May 1, 2015, AIAI entered into subordinated surplus debentures (“Surplus Notes”) with the ASI Pool Companies that had a maturity date of April 30, 2020 carrying a variable interest equal to the corporate base rate as reported by the largest bank (measured in assets) with its head office located in Chicago, Illinois, in effect on the first business day of each month for the term of the Surplus Notes plus two percent per annum on the unpaid principal balance with a maximum variable interest rate for any month not to exceed the initial rate for the Surplus Notes by more than ten percent per annum. These Surplus Notes are subject to various terms and conditions as set forth by the Illinois Department of Insurance and require prior written approval for the payment of interest and/or a reduction in principal. AIAI stopped accruing the interest receivable on these notes at their maturity date. These Surplus Notes could be used at some point by AIAI to offset future amounts payable due to the estates of the ASI Pool Companies related to income tax settlements and various other amounts due to the estates of the ASI Pool Companies that are in liquidation.
Discontinued Operations
During the fourth quarter of 2019, the Company began actively pursuing the potential sale of Global Liberty, and as a result, Global Liberty has been classified as a discontinued operation and the assets and liabilities are reported as held for sale and results of Global Liberty’s operations are reported separately for all periods presented. Global Liberty has not been sold within the one year guidance as set forth by ASC 205-20 (Discontinued Operations) to continue classifying Global Liberty as a discontinued operations. However, due to the confluence of events and circumstances beyond the Company’s control, ASC 205-20 provides for an exception to the one year guidance which the Company believes fits its situation. As a result of the Company applying the exception guidance, Global Liberty remains a discontinued operation as of June 30, 2021. The Company continues to move forward with the plans of selling Global Liberty pending certain regulatory and other matters that must occur prior to such sale.
Summary financial information for Global Liberty included in (loss) income from discontinued operations, net of tax in the condensed consolidated statements of operations for the three and six months ended June 30, 2021 and 2020 is presented below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Loss) Income from Discontinued Operations
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Net premiums earned
|
$
|
2,703
|
|
$
|
2,973
|
|
$
|
5,301
|
|
$
|
7,840
|
|
Net investment (loss) income
|
(29)
|
|
12
|
|
(93)
|
|
(17)
|
|
Net realized gains (losses)
|
—
|
|
—
|
|
145
|
|
(1,565)
|
|
Total revenue
|
2,674
|
|
2,985
|
|
5,353
|
|
6,258
|
|
Net claims incurred
|
1,565
|
|
1,757
|
|
2,448
|
|
2,353
|
|
Acquisition costs
|
495
|
|
361
|
|
1,405
|
|
2,429
|
|
Other underwriting expenses
|
615
|
|
970
|
|
1,349
|
|
2,158
|
|
|
|
|
|
|
Total expenses
|
2,675
|
|
3,088
|
|
5,202
|
|
6,940
|
|
(Loss) income from operations before income taxes
|
(1)
|
|
(103)
|
|
151
|
|
(682)
|
|
Income tax benefit
|
—
|
|
—
|
|
—
|
|
(522)
|
|
Net (loss) income
|
$
|
(1)
|
|
$
|
(103)
|
|
$
|
151
|
|
$
|
(160)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Statements of Comprehensive Loss (Income)
|
($ in ‘000s)
|
Three months ended June 30,
|
Six months ended June 30,
|
|
2021
|
2020
|
2021
|
2020
|
Net (loss) income
|
$
|
(1)
|
|
$
|
(103)
|
|
$
|
151
|
|
$
|
(160)
|
|
|
|
|
|
|
Other comprehensive (loss) income:
|
|
|
|
|
Changes in net unrealized investments (gains) losses
|
(9)
|
|
303
|
|
(22)
|
|
245
|
|
Reclassification to net (loss) income
|
(1)
|
|
(2)
|
|
(159)
|
|
(93)
|
|
Other comprehensive (loss) income
|
(10)
|
|
301
|
|
(181)
|
|
152
|
|
Total comprehensive (loss) income
|
$
|
(11)
|
|
$
|
198
|
|
$
|
(30)
|
|
$
|
(8)
|
|
|
|
|
|
|
The assets and liabilities of Global Liberty are presented as discontinued operations and included in assets and liabilities held for sale in the condensed consolidated statements of financial position at June 30, 2021 and December 31, 2020 and are detailed as follows:
|
|
|
|
|
|
|
|
|
($ in ‘000s)
|
June 30, 2021
|
December 31, 2020
|
Assets
|
|
|
Investments
|
|
|
Fixed income securities, available for sale, at fair value (amortized cost $1,647 and $4,315)
|
$
|
1,695
|
|
$
|
4,544
|
|
|
|
|
Other investments
|
1,307
|
|
1,319
|
|
Total investments
|
3,002
|
|
5,863
|
|
Cash and cash equivalents
|
4,130
|
|
3,029
|
|
Accrued investment income
|
10
|
|
29
|
|
Reinsurance recoverables on amounts paid
|
780
|
|
581
|
|
Reinsurance recoverables on amounts unpaid
|
35,480
|
|
31,958
|
|
Prepaid reinsurance premiums
|
332
|
|
9,739
|
|
Deferred policy acquisition costs
|
329
|
|
637
|
|
Other assets
|
807
|
|
2,049
|
|
Total assets
|
$
|
44,870
|
|
$
|
53,885
|
|
|
|
|
Liabilities
|
|
|
Claims liabilities
|
$
|
38,201
|
|
$
|
38,499
|
|
Unearned premium reserves
|
5,364
|
|
14,545
|
|
Due to reinsurers
|
—
|
|
10
|
|
Other liabilities and accrued expenses
|
6,979
|
|
7,353
|
|
Total liabilities
|
$
|
50,544
|
|
$
|
60,407
|
|
|
|
|
16. Going Concern
Under ASC 205-40 (Going Concern), we have the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet our future financial obligations as they become due within one year after the date that the condensed consolidated financial statements are issued. As required by this standard, our evaluation shall initially not take into consideration the potential mitigating effects of our plans that have not been fully implemented as of the date the condensed consolidated financial statements are issued.
In complying with the requirements under ASC 205-40 to complete an evaluation without considering mitigating factors, the Company considered several conditions or events including (1) uncertainty around the continued impact of the COVID-19 pandemic on the Company’s operations and consolidated financial results, (2) the $25 million of Senior Unsecured Notes maturing on April 26, 2022, (3) recurring operating losses for fiscal periods through June 30, 2021, (4) the Company’s negative equity, and (5) the Company’s working capital limitations. The above conditions raise substantial doubt about the Company’s ability to continue as a going concern for the 12-month period following the date of the issuance of the June 30, 2021 interim financial statements.
In performing the second step of this assessment, we are required to evaluate whether our plans to mitigate the conditions above alleviate the substantial doubt about our ability to meet our obligations as they become due within one year after the date that the condensed consolidated financial statements are issued. Our future plans may potentially include, without limitation, one or more of the following: (1) securing incremental capital with the objective of potentially repurchasing some or all of the Senior Unsecured Notes at a discount to par, in the open market or otherwise, (2) securing equity or debt capital in private or public transactions, or (3) offering to exchange some or all of the Senior Unsecured Notes for debt, equity and/or other securities or other consideration, through privately negotiated transactions or otherwise. The constraints and requirements related to the Company’s current senior notes coupled with market conditions could create limitations with respect to such alternatives.
Management believes that the Company’s capital requirements will depend on many factors including the success of the Company’s business development efforts. Management also believes the Company may need to raise additional capital for working capital purposes. There is no assurance that such financing will be available in the future. The conditions described above raise substantial doubt about our ability to continue as a going concern. The condensed consolidated financial statements of the Company do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary should the Company be unable to continue as a going concern.
There is no assurance that sufficient funds required during the next year or thereafter will be generated from operations or that funds will be available through external sources. The lack of additional capital resulting from the inability to generate cash flow from operations or to raise capital from external sources would force the Company to substantially curtail or cease operations and would, therefore, have a material effect on the business. Furthermore, there can be no assurance that any such required funds, if available, will be available on attractive terms or will not have a significant dilutive effect on the Company’s existing shareholders. In the absence of the successful execution of one or more of the Company’s previously mentioned mitigating actions, we have therefore concluded there is substantial doubt about our ability to continue as a going concern through or beyond 12 months of the issue date of these interim financial statements.
The accompanying condensed consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from our failure to continue as a going concern.